Gordon Keller

Type: Person
Name: Gordon Keller
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

Sernova Agrees on Terms to Gain Access to Proprietary Stem Cell Technology For the Treatment of Diabetes

Sernova's advanced technologies aim to provide individuals with insulin-dependent diabetes freedom from insulin injections, pumps and daily blood glucose monitoringLONDON, ONTARIO--(Marketwired - July 15, 2014) - Sernova Corp. (TSX VENTURE:SVA) a clinical ... [Published MarketWired - Jul 15 2014]

More Content

All (1) | News (1) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Sernova Agrees on Terms to Gain Access to Propr... [Published MarketWired - Jul 15 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.